← All trials
NCT04521569
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 22, 2020
- Primary completion
- Jan 22, 2021
- Completion date
- Aug 31, 2022
- First posted
- Aug 20, 2020
- Last posted
- Sep 2, 2020
- Enrollment
- 46
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of MarylandLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of MarylandOverall official - principal investigator
- University of MarylandReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.